LAURA TABER: Open Payments
NPI 1538756952 · WEST CHESTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$289 in 16 payments from 9 companies in 2025. Trend: 2023 $435 · 2024 $435 · 2025 $289
Food & beverage: $289
| Company | Payments | Amount |
|---|---|---|
| Sage Therapeutics, LLC | 5 | $113 |
| Supernus Pharmaceuticals, Inc. | 2 | $47 |
| Sumitomo Pharma America, Inc. | 2 | $36 |
| Hologic Sales and Service, LLC | 1 | $18 |
| CooperSurgical, Inc. | 1 | $18 |
| Evofem Biosciences, Inc. | 1 | $17 |
| MILLICENT US INC | 1 | $16 |
| Davol Inc. | 1 | $15 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $9 |
Products named: ZURZUVAE, Qelbree, MYFEMBREE, APTIMA, Paragard T 380A, Phexxi, INTRAROSA, ARISTA.
Industry payments across PA — which companies pay providers there.
